Morgan Stanley Direct Lending (NYSE:MSDL – Get Free Report) and Ambu A/S (OTCMKTS:AMBBY – Get Free Report) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
Profitability
This table compares Morgan Stanley Direct Lending and Ambu A/S’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Morgan Stanley Direct Lending | 60.60% | 12.57% | 6.36% |
Ambu A/S | 8.55% | 8.09% | 6.39% |
Analyst Ratings
This is a breakdown of current ratings for Morgan Stanley Direct Lending and Ambu A/S, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Morgan Stanley Direct Lending | 0 | 5 | 1 | 0 | 2.17 |
Ambu A/S | 0 | 0 | 0 | 0 | N/A |
Earnings and Valuation
This table compares Morgan Stanley Direct Lending and Ambu A/S”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Morgan Stanley Direct Lending | $367.74 million | 4.81 | $231.01 million | $2.97 | 6.67 |
Ambu A/S | $684.60 million | 6.27 | $24.09 million | $0.20 | 91.40 |
Morgan Stanley Direct Lending has higher earnings, but lower revenue than Ambu A/S. Morgan Stanley Direct Lending is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.
Summary
Morgan Stanley Direct Lending beats Ambu A/S on 6 of the 10 factors compared between the two stocks.
About Morgan Stanley Direct Lending
Morgan Stanley Direct Lending Fund is a business development company. It is a non-diversified, externally managed specialty finance company focused on lending to middle-market companies. Morgan Stanley Direct Lending Fund is based in NEW YORK.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
Receive News & Ratings for Morgan Stanley Direct Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley Direct Lending and related companies with MarketBeat.com's FREE daily email newsletter.